Associated Papers
Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review.
Hoff FW et al.
British Journal of Haematology, 2026
Periorbital oedema, trismus, myalgia as muscular manifestations of VEXAS syndrome: a case report and narrative literature review.
Archambeaud A et al.
Rheumatology (oxford, England), 2026
VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies.
Groarke EM et al.
Lancet (london, England), 2026
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Martinez Rodriguez A et al.
British Journal of Haematology, 2026
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden.
Anderson M et al.
Arthritis & Rheumatology (hoboken, N.j.), 2026
Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management.
Elbadry MI et al.
Current Research in Translational Medicine, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations.
Sakuma M et al.
Leukemia, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter study.
Bourguiba R et al.
Journal of Internal Medicine, 2025
Coexistence of VEXAS Syndrome and Chronic Hepatitis B Virus Infection: a Case Report and Literature Review.
Lin K et al.
Clinical Reviews in Allergy & Immunology, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
From diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome.
Rana G et al.
Rheumatology International, 2025
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.
Fiumara M et al.
Expert Review of Hematology, 2025
Therapeutic Challenges in the Management of VEXAS Syndrome: A Case Report.
Kelly G et al.
The Australasian Journal of Dermatology, 2025
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder - A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape.
Singh A et al.
Journal of Autoimmunity, 2025
Utilizing C. elegans Spermatogenesis and Fertilization Mutants as a Model for Human Disease.
Perez SM et al.
Journal of Developmental Biology, 2025
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.
Costa A et al.
Annals of Hematology, 2025
Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature.
Alnahas Z et al.
Open Access Rheumatology : Research and Reviews, 2025
VEXAS: A review of current understandings and emerging treatment strategies.
Holden R et al.
Frontiers in Immunology, 2025
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.
Caggiano V et al.
Frontiers in Medicine, 2025
S56F UBA1 variant: a VEXAS syndrome subtype that follows its own path.
Rieu JB et al.
Blood, 2024
VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments.
Alqatari S et al.
Journal of Clinical Medicine, 2024
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome.
Dias AL et al.
Annals of Hematology, 2024
Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients.
Ali SB et al.
Clinical Rheumatology, 2024
VEXAS without vacuoles: Linking genotype to phenotype.
Zhukovsky S et al.
Ejhaem, 2024
Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront.
Li XX et al.
Molecular Medicine (cambridge, Mass.), 2024
Trismus as a new feature of VEXAS syndrome.
Archambeaud A et al.
Rheumatology (oxford, England), 2024
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging field.
Phan L et al.
Leukemia & Lymphoma, 2024
How I diagnose and manage VEXAS syndrome.
Hagiya A et al.
American Journal of Clinical Pathology, 2024
Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
Kouranloo K et al.
Rheumatology International, 2024
Distinct bone marrow findings associated with a noncanonical UBA1 variant in VEXAS syndrome.
Allison DR et al.
American Journal of Hematology, 2024
VEXAS-Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort.
Corty RW et al.
Arthritis & Rheumatology (hoboken, N.j.), 2024
Shared and distinct mechanisms of UBA1 inactivation across different diseases.
Collins JC et al.
The Embo Journal, 2024
VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
Saad AJ et al.
Experimental Dermatology, 2024